The Predictive Value of Serum HER2/neu for Response to Anthracycline-Based and Trastuzumab-Based Neoadjuvant Chemotherapy

PURPOSE: Little information exists about the possible influence of serum HER2/neu on response to chemotherapy. We propose that the assessment of serum HER2/neu in a pretreatment serum sample may be useful in predicting response to neoadjuvant chemotherapy. METHODS: All breast cancer patients were te...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung Sun, Son, Byung-Ho, Ahn, Sei Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395742/
https://www.ncbi.nlm.nih.gov/pubmed/22807936
http://dx.doi.org/10.4048/jbc.2012.15.2.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395742/
https://www.ncbi.nlm.nih.gov/pubmed/22807936
http://dx.doi.org/10.4048/jbc.2012.15.2.189

Ejemplares similares